273 results on '"Isobe, Yasushi"'
Search Results
2. Light-chain plasma cell myeloma caused by 14q32/IGH translocation and loss of the other allele
3. Defective Epstein–Barr virus in chronic active infection and haematological malignancy
4. An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome
5. Cell dynamics during differentiation therapy with all-trans retinoic acid in acute promyelocytic leukemia
6. Supplementary Figure 1 from Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type
7. Supplementary Figure Legend from Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type
8. A portion of expanded granular lymphocytes cause pure white cell aplasia?
9. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32)
10. Publisher Correction: Defective Epstein–Barr virus in chronic active infection and haematological malignancy
11. A clinically attainable dose of L-asparaginase targets glutamine addiction in lymphoid cell lines
12. Prospective measurement of Epstein-Barr virus–DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type
13. Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system
14. Correction to: Cell dynamics during differentiation therapy with all-trans retinoic acid in acute promyelocytic leukemia
15. Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy
16. Absence of tumor-specific over-expression of Polo-like kinase 1 (Plk1) in major non-Hodgkin lymphoma and relatively low expression of Plk1 in nasal NK/T cell lymphoma
17. Current and future perspectives on the TARGET system: the registration system for Glivec® established by the JSH
18. A novel chromosomal translocation t(1;14)(q25;q32) in pre-B acute lymphoblastic leukemia involves the LIM homeodomain protein gene, Lhx4
19. Aggressive natural killer cell leukemia: Therapeutic potential of l-asparaginase and allogeneic hematopoietic stem cell transplantation
20. T/NK cell type chronic active Epstein–Barr virus disease in adults: an underlying condition for Epstein–Barr virus-associated T/NK-cell lymphoma
21. Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infection
22. Identification of Bcl-2/IgH fusion sequences using real-time PCR and chip-based microcapillary electrophoresis
23. Identification of Bcl-2-IgH fusion sequences using real-time PCR and chip-based microcapillary electrophoresis
24. Suppression of eIF4E Expression by l-Asparaginase
25. Activity and safety of combination chemotherapy with methotrexate, ifosfamide, l-asparaginase and dexamethasone (MILD) for refractory lymphoid malignancies: a pilot study
26. Anti-thymocyte globulin therapy induced a spurious increase of fibrinogen degradation products in hypoplastic myelodysplastic syndrome
27. Clinical analysis of 52 patients with granular lymphocyte proliferative disorder (GLPD) showed frequent anemia in indolent T-cell GLPD in Japan
28. Thalidomide may induce interstitial pneumonia preferentially in Japanese patients
29. Expression levels of apoptosis-related proteins and Ki-67 in nasal NK / T-cell lymphoma
30. Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide
31. CD20-positive extranodal NK-cell lymphoma, nasal-type
32. Neural cell adhesion molecule (CD56)-positive B-cell lymphoma
33. Improvement of idiopathic thrombocytopenic purpura by antithyroid therapy
34. Epstein–Barr virus-associated T-cell acute lymphoblastic leukaemia
35. Efficient recruitment of c‐FLIP L to the death‐inducing signaling complex leads to Fas resistance in natural killer‐cell lymphoma
36. Detection of chimaeric transcripts of the immunoglobulin heavy chain and BCL6 genes by reverse-transcriptase polymerase chain reaction in B-cell non-Hodgkin's lymphomas
37. Disseminated Mucor infection and thrombotic microangiopathy in lymphoma-associated hemophagocytic syndrome
38. Multiple brain infarctions induced by imatinib mesylate in a patient with clonal eosinophilia
39. Efficient recruitment of c‐FLIPL to the death‐inducing signaling complex leads to Fas resistance in natural killer‐cell lymphoma.
40. Targeting BCL2 with venetoclax is a promising therapeutic strategy for “double-proteinexpression” lymphoma with MYC and BCL2 rearrangements
41. Bone Marrow Biopsy Is Still Indispensable for Evaluating Bone Marrow Involvement in DLBCL Patients Even in the PET/CT Era
42. The Presence of Defective Epstein-Barr Virus (EBV) Infection in Patients with EBV-Associated Hematological Malignancy
43. Results of Alumina-Ceramic Endoprostheses Used for Bone Tumor Cases
44. Limiting Factors of Limb Salvage Operation for Musculoskeletal Sarcoma
45. Functional Evaluation of Limb Salvage Operation for Malignant Bone and Soft Tissue Tumors Using the Evaluation System of the Musculoskeletal Tumor Society
46. Expression of activating natural killer‐cell receptors is a hallmark of the innate‐like T‐cell neoplasm in peripheral T‐cell lymphomas
47. De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a case report and literature review
48. Mantle Cell Lymphoma Is Associated with a Variable Number of PD-1-Positive Tumor Infiltrating T-Cells
49. The Long Form of Cellular FLIP Renders NK-Cell Lymphoma Cells Resistant to Fas-Mediated Apoptosis
50. A monoclonal expansion of Epstein–Barr virus-infected natural killer cells after allogeneic peripheral blood stem cell transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.